搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
15 小时
on MSN
22-Year-Old With Chronic Asthma Died After Inhaler Price Went From $66 to $539: Lawsuit
The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and ...
Enumclaw Courier-Herald
1 天
Breathe Drops for Respiratory Relief Exposed: The Truth About Its Benefits for COPD and Asthma
In a world where respiratory issues are increasingly common, finding practical solutions can be daunting. Breathe Drops ...
1 天
New AI tool that provides treatment plan for asthma may lead to sufferers being symptom-free
A Victorian-based company is using AI to help “map” and personalise the best treatment for patients with respiratory ...
Fierce Healthcare
2 天
HCSC tightens asthma infusion coverage, providers slam decision
Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...
gastroenterologyadvisor
3 天
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities.
Knowridge
5 天
First new treatment for asthma and COPD in half a century – new study
If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
6 天
China Medical System(00867)Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Rα ...
Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanizedmonoclonal antibody that simultaneously blocks the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈